Abstract

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2021 - Volume 25, Number 2

Page(s): 145

Download in electronic PDF format for $75
  • Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • levodopa
  • carbidopa
  • parkinsonian syndrome
  • parkinsonism
  • decarboxylase inhibitor
  • stability

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • DOSAGE FORMS/DRUG CARRIERS
  • MUSCULOSKELETAL DISORDERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2021
Pg. 145
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 149
Levodopa and Carbidopa Rectal Suspension
Author(s): Allen Loyd V Jr
May/Jun 2002
Pg. 202
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 70
Carbidopa 1.25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 318
Lisinopril 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 491
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 494
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 138
Topiramate 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 224
Baclofen 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 315
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 421
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 233
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 508
Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 417
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 327-336
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Jan/Feb 2020
Pg. 55
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 408
Dipyridamole 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 234
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr